Welling Anne
Emergency Department, QAH, Cosham, Portsmouth, Hants PO3 6LY, UK.
Emerg Med J. 2007 Jun;24(6):408-12. doi: 10.1136/emj.2007.047324.
To test the analgesic efficacy of topical morphine on superficial burns within the emergency department by comparing pain scores, comfort ratings and analgesia taken by participants.
A placebo-controlled three-treatment randomised controlled trial was undertaken. 59 participants were randomly allocated to receive a dressing containing Intrasite gel and morphine sulphate, Intrasite gel and water or the conventional Jelonet dressing. The study design enabled double-blinding between the two Intrasite gel treatments.
49 participants were included in the final analysis as 10 were lost to follow-up. No significant differences were observed between the pain scores or comfort ratings of the three treatments. Participants receiving Jelonet and the placebo reduced their pain scores by the greatest amount overall. However, participants receiving morphine were the only group to reduce pain scores by >20 mm on two consecutive time intervals (2 and 6 h). At 12 h the morphine group reported the highest pain scores. Only 4/15 participants receiving topical morphine administered additional analgesia compared with 12/17 receiving the Jelonet dressing and 6/17 receiving Intrasite and water (p = 0.055). However, when all analgesia was taken into account, the morphine group was administered the greatest amount. Overall, the placebo group reported their dressings to be the most comfortable and took the least amount of analgesia. Minor adverse reactions included itching, burning and a rash. No serious adverse reactions were reported.
Topical morphine sulphate does not seem to be as effective when used for the pain associated with superficial burns as when used for the pain associated with chronic inflammatory wounds. (The European Clinical Trials Database number for this study is 2005-003285-42.).
通过比较参与者的疼痛评分、舒适度评级和使用的镇痛药物,测试急诊科局部应用吗啡对浅表烧伤的镇痛效果。
进行了一项安慰剂对照的三治疗组随机对照试验。59名参与者被随机分配接受含有安尔碘凝胶和硫酸吗啡的敷料、安尔碘凝胶和水或传统的杰隆尼特敷料。该研究设计实现了两种安尔碘凝胶治疗之间的双盲。
最终分析纳入了49名参与者,10名失访。三种治疗的疼痛评分或舒适度评级之间未观察到显著差异。接受杰隆尼特敷料和安慰剂的参与者总体上疼痛评分降低幅度最大。然而,接受吗啡的参与者是唯一在两个连续时间间隔(2小时和6小时)疼痛评分降低超过20毫米的组。在12小时时,吗啡组报告的疼痛评分最高。接受局部应用吗啡的15名参与者中只有4人使用了额外的镇痛药物,相比之下,接受杰隆尼特敷料的17人中有12人、接受安尔碘凝胶和水的17人中有6人使用了额外镇痛药物(p = 0.055)。然而,考虑所有镇痛药物后,吗啡组使用的剂量最大。总体而言,安慰剂组报告其敷料最舒适,使用的镇痛药物最少。轻微不良反应包括瘙痒、烧灼感和皮疹。未报告严重不良反应。
局部应用硫酸吗啡用于浅表烧伤相关疼痛时似乎不如用于慢性炎症性伤口相关疼痛时有效。(本研究的欧洲临床试验数据库编号为2005 - 003285 - 42。)